Who owns Ovid Therapeutics Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of OVID from SEC Form 13F filings across 130 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 130 institutions disclosed 147.0M shares of Ovid Therapeutics Inc. worth $395.5M — about 199.4% of shares outstanding; the largest disclosed holder is Jupiter Topco LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
130
13F holders
$395.5M
value, 2026 filers
199.4%
of shares outstanding (147.0M sh)
46
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of OVID's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Jupiter Topco LLCNEW | 20.7M | $55.9M | 0.0% | 28.1% | new |
| 2 | EVENTIDE ASSET MANAGEMENT, LLC | 11.8M | $31.8M | 0.4% | 16% | +19.1% |
| 3 | BlackRock, Inc. | 10.8M | $29.1M | 0.0% | 14.7% | +605.9% |
| 4 | RA CAPITAL MANAGEMENT, L.P. | 10.5M | $28.2M | 0.2% | 14.2% | -2.0% |
| 5 | Affinity Asset Advisors, LLC | 10.1M | $27.3M | 1.2% | 13.8% | -4.6% |
| 6 | STATE STREET CORP | 7.9M | $21.3M | 0.0% | 10.7% | +1418.6% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 7.8M | $20.9M | 0.0% | 10.5% | +47.6% |
| 8 | ADAR1 Capital Management, LLC | 7.4M | $20.0M | 0.9% | 10.1% | +63.2% |
| 9 | Balyasny Asset Management L.P. | 6.7M | $18.1M | 0.0% | 9.1% | +21.4% |
| 10 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 6.2M | $16.6M | 0.0% | 8.4% | 0.0% |
| 11 | FEDERATED HERMES, INC. | 6.0M | $16.0M | 0.0% | 8.1% | +66.7% |
| 12 | BRAIDWELL LPNEW | 5.9M | $15.9M | 0.6% | 8% | new |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 4.1M | $11.0M | 0.0% | 5.5% | +209.0% |
| 14 | SILVERARC CAPITAL MANAGEMENT, LLC | 3.1M | $8.3M | 0.9% | 4.2% | +210.1% |
| 15 | STEMPOINT CAPITAL LPNEW | 2.4M | $6.5M | 1.1% | 3.3% | new |
| 16 | Ikarian Capital, LLC | 2.3M | $6.1M | 0.7% | 3.1% | -21.6% |
| 17 | Point72 Asset Management, L.P. | 1.9M | $5.2M | 0.0% | 2.6% | +47.3% |
| 18 | SPHERA FUNDS MANAGEMENT LTD. | 1.4M | $3.6M | 0.5% | 1.8% | -16.6% |
| 19 | NORTHERN TRUST CORP | 1.2M | $3.4M | 0.0% | 1.7% | +389.1% |
| 20 | VANGUARD FIDUCIARY TRUST CO | 1.1M | $3.1M | 0.0% | 1.5% | +64.6% |
| 21 | Propel Bio Management, LLC | 1.1M | $3.0M | 1.6% | 1.5% | +21.1% |
| 22 | Rosalind Advisors, Inc. | 1.1M | $3.0M | 1.1% | 1.5% | 0.0% |
| 23 | VANGUARD PORTFOLIO MANAGEMENT LLCNEW | 1.0M | $2.8M | 0.0% | 1.4% | new |
| 24 | Sio Capital Management, LLC | 1.0M | $2.7M | 0.4% | 1.4% | -19.7% |
| 25 | Ensign Peak Advisors, IncNEW | 988,084 | $2.7M | 0.0% | 1.3% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.